Xin-Hua Feng

Title: Innovations of Xin-Hua Feng in Gene Expression Suppression

Introduction

Xin-Hua Feng is an accomplished inventor based in Houston, TX (US). He has made significant contributions to the field of gene expression suppression. His innovative work has implications for both biomedical research and medicinal products.

Latest Patents

Xin-Hua Feng holds a patent for gene expression suppression agents. This patent describes a method for creating gene suppression agents for use in eukaryotic cells. The method utilizes a recombinant DNA construct that includes at least one transcriptional unit, which comprises a transcriptional promoter, a template sequence for RNA molecule synthesis, and a transcriptional terminator. The mechanisms of RNA-mediated gene suppression include RNA interference (RNAi). The patent also discusses the application of these agents as tools for biomedical research and as potential medicinal products.

Career Highlights

Xin-Hua Feng is currently employed at Potomac Pharmaceuticals, Inc. His work at the company focuses on advancing the understanding and application of gene suppression technologies. With a patent portfolio that includes 1 patent, he has established himself as a key figure in his field.

Collaborations

Xin-Hua Feng collaborates with Yingxian Xiao, who is also a notable professional in the industry. Their partnership enhances the research and development efforts at Potomac Pharmaceuticals, Inc.

Conclusion

Xin-Hua Feng's innovative work in gene expression suppression represents a significant advancement in biotechnology. His contributions have the potential to impact various fields, including medicine and research.